Volume 24, Issue 3 (May-June 2025)
Payesh 2025, 24(3): 389-397 |
Back to browse issues page
Ethics code: IR.TUMS. MEDICINE. 1400.1045
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mosleh A, Amini N, Sehati M, Soroush M. The effect of harm-free pharmacotherapy training program on awareness and performance of type 2 diabetic patients. Payesh 2025; 24 (3) :389-397
URL: http://payeshjournal.ir/article-1-2486-en.html
URL: http://payeshjournal.ir/article-1-2486-en.html
1- Tehran University of Medical Sciences, Tehran, Iran
Abstract: (361 Views)
Objective(s): There is a possibility of serious harm to the patient with misuse of drugs, so it is important to pay attention to the safety of drug use. In this study, the effect of non-harm drug therapy education on the level of knowledge and performance of type 2 diabetic patients in primary health care programs was evaluated.
Methods: This was an experimental study covering urban and rural health centers in Tehran. Health center were randomly selected and the number of samples were determined based on the population density covered by the centers. The sample size was estimated to be 496, and the selection of intervention and control samples in each pharmacy was done randomly when the patient visited. The measurement tool in this research was a self-designed questionnaire including 2 areas of drug therapy without injury, and 5 structures (1-starting drug use, 2-taking own drug, 3-adding another drug, 4-reviewing own drugs, 5-discontinuing drug use).and the educational intervention included face-to-face training and delivery of pamphlets.
Results: The data for 496 patients (277 the intervention group and 219 the control group) were assessed. In terms of demographic information, except for educational qualification (P = 0.046), there was no significant difference between the intervention and the control group. Comparison of the average score of awareness after the intervention between the study groups was significant (p=0.001). Also the comparison of the average performance score before and after the intervention in the test group (p < 0.001) was significant.
Conclusion: Education of drug therapy for patients with type 2 diabetes at primary health centers increases the awareness and performance of patients.
Methods: This was an experimental study covering urban and rural health centers in Tehran. Health center were randomly selected and the number of samples were determined based on the population density covered by the centers. The sample size was estimated to be 496, and the selection of intervention and control samples in each pharmacy was done randomly when the patient visited. The measurement tool in this research was a self-designed questionnaire including 2 areas of drug therapy without injury, and 5 structures (1-starting drug use, 2-taking own drug, 3-adding another drug, 4-reviewing own drugs, 5-discontinuing drug use).and the educational intervention included face-to-face training and delivery of pamphlets.
Results: The data for 496 patients (277 the intervention group and 219 the control group) were assessed. In terms of demographic information, except for educational qualification (P = 0.046), there was no significant difference between the intervention and the control group. Comparison of the average score of awareness after the intervention between the study groups was significant (p=0.001). Also the comparison of the average performance score before and after the intervention in the test group (p < 0.001) was significant.
Conclusion: Education of drug therapy for patients with type 2 diabetes at primary health centers increases the awareness and performance of patients.
type of study: Quazi Experimental |
Subject:
Public Health
Received: 2024/04/7 | Accepted: 2025/05/27 | ePublished ahead of print: 2025/07/2 | Published: 2025/07/14
Received: 2024/04/7 | Accepted: 2025/05/27 | ePublished ahead of print: 2025/07/2 | Published: 2025/07/14
References
1. World Health Organization (2017). The third global patient safety challenge: tackling medication-related harm. Bulletin of the World Health Organ 2017;95:546-546A Available at: https://iris.who.int/bitstream/handle/10665/272147/PMC5537758.pdf?sequence=1. Accessed 30 March 2024 [DOI:10.2471/BLT.17.198002]
2. World Health Organization (2019). Medication without harm. WHO Global Patient Safety Challenge. Available at: https://iris.who.int/bitstream/handle/10665/255263/WHO-HIS-SDS-2017.6-eng.pdf?sequence=1. Accessed 30 March 2024
3. Centers for Disease Control and Prevention)CDC). Managing Hazardous Drug Exposures: Information for Healthcare Settings. Available at: https://www.cdc.gov/niosh/docs/2023-130/2023-130.pdf?id=10.26616/NIOSHPUB2023130. Accessed 30 March 2024
4. Zhou B et al. Worldwide trends in diabetes since 1980: A pooled analysis of 751 population-based studies with 4.4 million participants. Lancet 2016;38:71513-1530
5. Ershova M. Improving Drug Safety: A Global Challenge to Protect Public Health. Journal of Clinical Trials. 2023; 13:531
6. Knudsen, P., et al. High-risk medications identified from the Danish Patient Safety Database and the challenge of dissemination. Journal of Patient Safety and Risk Management 2018; 24:7-12 [DOI:10.1177/2516043518815020]
7. Zanzabil K.Z, Hossain M.S, Hasan M.K. Diabetes Mellitus Management: An Extensive Review of 37 Medicinal Plants. Diabetology 2023; 4; 186-234 [DOI:10.3390/diabetology4020019]
8. Červený M, Hajduchová H, Brabcová I, Chloubová I, Prokešová R, Malý J et al. Self-reported medication administration errors in clinical practice of nurses: a descriptive correlation study. Medycyna Pracy 2023; 74:85-92 [DOI:10.13075/mp.5893.01356]
9. Esteghamati A, Larijani B, Aghajani MH,Ghaemi F,Kermanchi J,Shahrami A et al. Diabetes in Iran: Prospective Analysis from First Nationwide Diabetes Report of National Program for Prevention and Control of Diabetes (NPPCD-2016). Scientific Report 2017;7:13461 [DOI:10.1038/s41598-017-13379-z]
10. World Health Organization (2019). 5Moments for Medication Safty. Available at: https://iris.who.int/bitstream/handle/10665/311153/WHO-HIS-SDS-2019.4-eng.pdf?sequence=1 Accessed 14 May 2025
11. Razmara M, Jani M, Arab ahmadi A, Nikkhah beydokhti A, Kadkhoda N, Payandeh F et al The Effect of Lecture and Pamphlet Education on Self-Care of Type 2 Diabetic Patients. The Horizon of Medical Education Development Journal 2023;14:63-54 [ Persian]
12. Jalilian F, Zinat Motlagh F, Solhi M. Effectiveness of Education Program on Increasing Self Management Among Patients with Type II Diabetes. Journal of Ilam University of Medical Sciences 2012; 20:26-34[Persian]
13. Asghari M, Naghibi A, Rostami F. An Investigation of the Effect of Training on Self-Care Promotion in Type 2 Diabetic Patients in Noor Health Center in 2015. Journal of Health Research in Community 2015;1: 22-28[ Persian]
14. Khamseh M.E, Nakhjavani M, Hosseinpanah F, Kalantari S, Sanjari M, Mohammadbeigi M. Metabolic control and prevalence of diabetes related complications in patients with type 2 diabetes: baseline results of the A1chieve study. Payesh 2014; 13:705-712[Persian]
15. Larijani B, Farzadfar B, Nasliesfahani E, Naderimagham SH, Paikariy N, SHarghi S. National framework for providing services in diabetes. National Committee for Prevention and Control of Infectious Diseases. 2st Edition, Garce: Karaj, 2018 [in Persian]
16. Herath HMM, Weerasinghe NP, Dias H, Weerarathna TP. Knowledge, attitude and practice related to diabetes mellitus among the general public in Galle district in Southern Sri Lanka: a pilot study. BMC Public Health 2017; 17:535 [DOI:10.1186/s12889-017-4459-5]
17. Wu AW. The "sixth right" of medication use: Medication without harm. Journal of Patient Safety and Risk Management 2019; 24:3-4 [DOI:10.1177/2516043519828027]
Send email to the article author
| Rights and Permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |